Directorate Change

RNS Number : 2246A

Alliance Pharma PLC

18 December 2014

 



For Immediate Release

18 December 2014

ALLIANCE PHARMA PLC

("Alliance" or the "Company")

Directorate Change

Alliance Pharma plc (AIM: APH), the speciality pharmaceutical company, confirms that, further to the announcement on 30 December 2013, Paul Ranson will retire from his position as Non-Executive Director of the Company on 31 December 2014.

For further information:

Alliance Pharma plc	+ 44 (0) 1249 466966
John Dawson, Chief Executive
Richard Wright, Finance Director
www.alliancepharma.co.uk
Buchanan	+ 44 (0) 20 7466 5000
Mark Court / Sophie Cowles / Jane Glover
Numis Securities Limited	+ 44 (0) 20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: David Poutney

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.

 

END

 

 

BOAZMMMZKRFGDZM